FIELD: medicine. SUBSTANCE: method involves determining low avidity antibodies secretion growth in blood serum or secrets relative to normal level. Normal antibodies of G class of low avidity and/or specific to antigens of G class antibodies are transformed into high avidity ones in blood serum and/or lymph and/or secrets by exerting selective action upon intramolecular interdomain links by applying physical and/or chemical and/or biological factors to determine structural and/or functional and/or protective properties of antibodies and/or SH groups availability in IgG before and after applying the transforming action. Relations binding results obtained before and after low avidity antibody transformation are determined for each feature, respectively. Modulation index is calculated and interpreted in terms of immunologic insufficiency and its manifestation degree and/or immunologic insufficiency form as preclinical latent development one (LII-1 or LII-2) or clinically marked one (II-1 or II-2) and/or immunity stress and immune response efficiency in progress and antibody maturity process dysfunction in plasmatic cells. EFFECT: enhanced accuracy of diagnosis. 10 cl, 12 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF IMMUNOCORRECTING THERAPY OF PRECLINICAL AND CLINICALLY EXPRESSED FORMS OF IMMUNOLOGICAL INSUFFICIENCY AND EXPRESS-SELECTION OF AGENTS FOR IMMUNOCORRECTION | 2000 |
|
RU2191385C2 |
EXPRESS-METHOD FOR ESTIMATION OF FUNCTIONAL ACTIVITY OF IMMUNITY B-SYSTEM | 1996 |
|
RU2137133C1 |
METHOD AND DEVICE FOR ADMINISTERING PHOTOIMMUNOMODULATION THERAPY | 2000 |
|
RU2240843C2 |
METHOD FOR DETERMINATION OF PREPARATION INFLUENCE ON INTERACTION OF COMPLEMENT WITH ANTIGEN-ANTIBODY COMPLEX | 2017 |
|
RU2669342C1 |
METHOD OF TREATING COVID-19 USING OX40 (CD134) RECEPTOR AGONISTS | 2020 |
|
RU2826983C2 |
METHOD OF DETERMINING AVIDITY OF IMMUNOGLOBULIN G TO HERPES VIRUS TYPE 6 | 2015 |
|
RU2596794C1 |
HUMAN IMMUNOGLOBULIN PREPARATION AGAINST CYTOMEGALOVIRUS AND METHOD FOR ITS PREPARING | 2002 |
|
RU2239453C2 |
DIAGNOSTIC TECHNIQUE FOR ACUTE VIRAL HEPATITIS A IN CHILDREN | 2011 |
|
RU2479847C2 |
METHOD FOR ENZYME IMMUNOASSAY DETERMINATION OF THE LEVEL OF ANTIGEN-RECOGNIZING B-LYMPHOCYTE RECEPTORS REPRESENTED BY MEMBRANE-SPECIFIC RBD PROTEIN SARS-COV-2, IgG ANTIBODIES | 2021 |
|
RU2760438C1 |
VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
Authors
Dates
2003-01-10—Published
2000-03-06—Filed